L. Laurenzi

Cutaneous bacterial colonization, modalities of chemotherapeutic infusion, and catheter-related bloodstream infection in totally implanted venous access devices

C. Benedetti, W. Tirelli, E. Arcuri, 2004, Supportive Care in Cancer.

SIAARTI recommendations for analgo-sedation in intensive care unit.

F. Paoletti, L. Bertini, F. Petrini, 2006, Minerva anestesiologica.

Toxic shock syndrome due to group C Streptococci A case report

C. Fimiani, A. Calamaro, E. Arcuri, 1996, Intensive Care Medicine.

Opioid nonresponsiveness in cancer pain can be reversible. A serendipitous conclusion of a refrospective analysis.

S. Mercadante, W. Tirelli, E. Arcuri, 2000, Journal of pain and symptom management.

Peritonectomy and hyperthermic antiblastic perfusion in the treatment of peritoneal carcinomatosis.

D. Giannarelli, R. Cavaliere, L. Aloe, 2000, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Long-term central venous catheterization via persistent left superior vena cava

L. Pelagalli, E. Arcuri, M. Marcelli, 2003, Supportive Care in Cancer.

Systemic and haemodynamic toxicity after isolated limb perfusion (ILP) with TNF-alpha.

F. Cavaliere, A. Calamaro, E. Arcuri, 2004, Journal of experimental & clinical cancer research : CR.

Biosimilar filgrastim (Zarzio®) vs. lenograstim (Myelostim®) for peripheral blood stem cell mobilization in adult patients with lymphoma and myeloma: a single center experience

L. Pierelli, F. Pisani, A. Mengarelli, 2016, Leukemia & lymphoma.

Treatment of peritoneal carcinomatosis with intent to cure

D. Giannarelli, R. Cavaliere, M. Cosimelli, 2000, Journal of surgical oncology.

Complications with fully implantable venous access systems in oncologic patients.

W. Tirelli, C. Fimiani, E. Arcuri, 1996, Tumori.

[Transdermal route as an alternative to oral administration of opioids in cancer pain].

W. Tirelli, E. Arcuri, P. Ginobbi, 1998, La Clinica terapeutica.

Hyperthermic antiblastic perfusion with TNFalpha and melphalan in stage III limb melanoma patients: A phase I - II SITILO study.

C. Rossi, F. Cavaliere, P. Perri, 2003, Journal of experimental & clinical cancer research : CR.